HLA-DQ BETA-CHAIN POLYMORPHISM LINKED TO MYASTHENIA GRAVIS

This publication has 13 references indexed in Scilit:

• Polymorphic restriction endonuclease sites linked to the HLA-DR alpha gene: localization and use as genetic markers of insulin-dependent diabetes.
  Proceedings of the National Academy of Sciences, 1985
• Genetic restriction of autoreactive acetylcholine receptor-specific T lymphocytes in myasthenia gravis.
  The Journal of Immunology, 1985
• A systematic study of HLA class II-beta DNA restriction fragments in insulin-dependent diabetes mellitus.
  Proceedings of the National Academy of Sciences, 1985
• Mutation at I-A beta chain prevents experimental autoimmune myasthenia gravis
  Immunogenetics, 1985
• Gene conversion between murine class II major histocompatibility complex loci. Functional and molecular evidence from the bm 12 mutant.
  The Journal of Experimental Medicine, 1984
• Cellular immune response to acetylcholine receptors in murine experimental autoimmune myasthenia gravis: Inhibition with monoclonal anti-I-A antibodies
  Cellular Immunology, 1983
• In vivo therapy with monoclonal anti-I-A antibody suppresses immune responses to acetylcholine receptor
  Proceedings of the National Academy of Sciences, 1983
• Genetic control of experimental autoimmune myasthenia gravis in mice. III. Ia molecules mediate cellular immune responsiveness to acetylcholine receptors.
  The Journal of Immunology, 1982
• Association of HLA—B8, DRw3, and Anti‐Acetylcholine Receptor Antibodies in Myasthenia Gravis
  Tissue Antigens, 1978
• Pathological mechanisms in experimental autoimmune myasthenia gravis. I. Immunogenicity of syngeneic muscle acetylcholine receptor and quantitative extraction of receptor and antibody-receptor complexes from muscles of rats with experimental automimmune myasthenia gravis.
  The Journal of Experimental Medicine, 1976